Stocks · Health care · Biological Products, (No Diagnostic Substances)

PRECISION BIOSCIENCES INC

DTIL Clue Score48
United States Fiscal year ends May CIK 0001357874 Results filed 3 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Michael Amoroso
4 Nov 2024
President and CEO
Sell
3,012
$8.19
$24.67K
J. Jefferson Smith
10 Jun 2024
Chief Research Officer
Sell
50
$11.79
$589.50
Michael Amoroso
2 May 2024
President and CEO
Sell
1,526
$10.32
$15.75K
Alan List
2 May 2024
Chief Medical Officer
Sell
290
$10.32
$2.99K
J. Jefferson Smith
2 May 2024
Chief Research Officer
Sell
154
$10.32
$1.59K
Alan List
30 Apr 2024
Chief Medical Officer
Sell
238
$10.03
$2.39K
J. Jefferson Smith
23 Jan 2024
Chief Research Officer
Sell
28,000
$0.37
$10.36K
Alan List
6 Mar 2023
Chief Medical Officer
Sell
9,473
$1.07
$10.14K
Dario Scimeca
6 Mar 2023
General Counsel and Secretary
Sell
12,172
$1.07
$13.02K
Michael Amoroso
17 Oct 2022
President and CEO
Sell
11,006
$1.32
$14.53K
Dario Scimeca
8 Jun 2022
General Counsel and Secretary
Sell
9,833
$2.06
$20.26K
Derek Jantz
8 Jun 2022
Chief Scientific Officer
Sell
18,849
$2.06
$38.83K
Alan List
27 Apr 2022
Chief Medical Officer
Sell
7,775
$2.10
$16.33K
Derek Jantz
17 May 2021
Chief Scientific Officer
Sell
20,000
$9.38
$187.60K
David S. Thomson
21 Jan 2021
Chief Operating Officer
Sell
10,000
$16.49
$164.90K

What was left out

Form 4 filings counted 238
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 27
Sales straight out of an exercise 38
Sales at will 15
Transactions with no price 0
Shares from compensation/vesting 11,715,028
Sales filed before the plan box existed 8
History held since 29 Mar 2019